To scale up protein production in order to compare and advance antibody therapeutics against COVID-19 around the world through our interanional consortium.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Erica Ollmann SaphireResearch Location
United States of AmericaLead Research Institution
La Jolla Institute for ImmunologyResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
To scale up protein production in order to compare and advance antibody therapeutics against COVID-19 around the world through our interanional consortium.